Who is most vulnerable to the flu?
Getting the annual flu vaccine is especially important for those who are:
- 65 and older
- People with medical conditions, such as asthma, diabetes and chronic lung disease
- Pregnant women
- Those who live with or provide care for these individuals
Flu vaccination formulation
An FDA advisory committee met earlier this year to select the flu viruses for the composition of the vaccine for the 2022-23 U.S. flu season. This year’s flu vaccines are quadrivalent, which means they cover the four most likely strains of the flu virus expected this season (two A strains and two B strains). All available vaccines are also preservative-free and thimerosal-free, and do not contain gluten or latex.
The vaccines provided at UCLA Health include
- Fluarix - A standard-dose injection approved for people 6 months and older. May contain small amounts of egg protein. It is not for people with a severe egg allergy or history of anaphylaxis.
- Fluad adjuvanted vaccine – This standard dose vaccine is only recommended for people 65 and older. It contains an ingredient, called an adjuvant, that is added to help create a stronger immune response. It is not for people with a history of severe vaccine reaction or a severe egg allergy.
- Fluzone High-Dose - A high-dose injection for adults who are 65 years and older. Contains four times the amount of antigen as the Fluarix vaccine. If the high-dose vaccine is not available, patients may receive the standard dose Fluarix vaccine.
- FluMist - A nasal mist for children and adults between 2 and 49 years old. Not for people with decreased immunity.
- Flublok - A standard-dose injection for people with severe egg/egg-protein allergies.